Literature DB >> 33952657

Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada.

Robert I Colautti1, Prameet M Sheth2,3,4,5, Calvin P Sjaarda6,7, Jennifer L Guthrie8, Samira Mubareka9,10, Jared T Simpson11,12, Bettina Hamelin13, Henry Wong2, Leanne Mortimer14,15,16, Robert Slinger16,17, Andrew G McArthur18,19,20, Marc Desjardins14,21, Allison McGeer22,23, Tony Mazzulli8,10,22, Katya Douchant3, Danielle Brabant-Kirwan24, Ramzi Fattouh25, Aaron Campigotto10,26, Samir N Patel8,10, Nahuel Fittipaldi8,10,23.   

Abstract

Genome-wide variation in SARS-CoV-2 reveals evolution and transmission dynamics which are critical considerations for disease control and prevention decisions. Here, we review estimates of the genome-wide viral mutation rates, summarize current COVID-19 case load in the province of Ontario, Canada (5 January 2021), and analyze published SARS-CoV-2 genomes from Ontario (collected prior to 24 November 2020) to test for more infectious genetic variants or lineages. The reported mutation rate (∼10-6 nucleotide [nt]-1 cycle-1) for SARS-CoV-2 is typical for coronaviruses. Analysis of published SARS-CoV-2 genomes revealed that the G614 spike protein mutation has dominated infections in Ontario and that SARS-CoV-2 lineages present in Ontario have not differed significantly in their rate of spread. These results suggest that the SARS-CoV-2 population circulating in Ontario has not changed significantly to date. However, ongoing genome monitoring is essential for identification of new variants and lineages that may contribute to increased viral transmission.
Copyright © 2021 Sjaarda et al.

Entities:  

Keywords:  COVID-19; G614D; PANGOLIN lineage; SARS-CoV-2; epidemiology; genetics; infectious disease; public health

Mesh:

Substances:

Year:  2021        PMID: 33952657     DOI: 10.1128/mSphere.00011-21

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  2 in total

1.  RNA polymerase inaccuracy underlies SARS-CoV-2 variants and vaccine heterogeneity.

Authors:  Christophe Herman; Catherine Bradley; Alasdair Gordon; Chen Wang; Matthew Cooke; Brendan Kohrn; Scott Kennedy; Olivier Lichtarge; Shannon Ronca
Journal:  Res Sq       Date:  2022-06-02

2.  High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants.

Authors:  Zita Hubler; Xiao Song; Cameron Norris; Mehul Jani; David Alouani; Maureen Atchley; Lisa Stempak; Sarah Cherian; Christine Schmotzer; Navid Sadri
Journal:  Am J Clin Pathol       Date:  2022-06-07       Impact factor: 5.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.